Browse diseases

…ESCMID Global, 2025) in Vienna, Austria. Granular study data on Herpes Zoster occurrence in adults with haematological malignancies have been…

…):2105–2114. PMID: 29296857McDonnell SRP, et al. Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an aut…

…al therapy, we conjugated cs21 to a CD45 targeting antibody. In B16F10 melanoma, αCD45-cs21 induced robust pSTAT3 in CD45+ cells in the tumor d…

…> 100), CrCl (53%, median 45), platelet count (50%, median 75), autoimmune disease (47%), hemoglobin (39%, median 8), and age (13%, median 75).At …

…sease are more likely to develop psychiatric disorders, such as schizophrenia, the risk in patients who test positive for ANA but who never d…

…Congenital heart disease (CHD) is the most common congenital anomaly, with lifelong impl…

…onth. This case highlights an unusual constellation of PG, GCA, rheumatoid arthritis and optic neuritis, with herpes zoster as a potential pathergic…

…kely to have LT (sHR 3.80, 95% CI 1.31 to 10.98). Patients with metabolic disease were nearly five times (sHR 5.05, 95% CI 3.60 to 7.08) and thos…

…48), diabetes mellitus (OR 4.17; 95% CI 1.81 to 9.63; p<0.001), autoimmune disease (OR 4.69; 95% CI 1.15 to 19.09; p=0.031), chemotherapy or radio…

…AC-positive patients (5.2 WP).Autoimmune disease, predominantly SLE, was present in 71% of LAC-negative and 68% of LAC-positive pat…

…potential therapeutic benefits in autoimmune disease, including Systemic Lupus Erythematous (SLE). The Phase 2b CARE study was a double-blind, randomized, …

…S1PR1 receptor modulator with potential therapeutic benefits in autoimmune disease. The Phase 2b CARE study ( NCT03742037) evaluated the efficacy …